Viewing Study NCT01725256


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2025-12-25 @ 9:21 PM
Study NCT ID: NCT01725256
Status: TERMINATED
Last Update Posted: 2014-04-09
First Post: 2012-11-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
Sponsor: Aires Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module